Dr Jeffrey Pantano, DPM | |
100 Hospital Dr, Bennington, VT 05201-5004 | |
(802) 442-6361 | |
Not Available |
Full Name | Dr Jeffrey Pantano |
---|---|
Gender | Male |
Speciality | Podiatry |
Experience | 8 Years |
Location | 100 Hospital Dr, Bennington, Vermont |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1295187300 | NPI | - | NPPES |
061.0000020 | Other | VT | MEDICAL LICENSE NUMBER |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213ES0103X | Podiatrist - Foot & Ankle Surgery | 061.0000020 (Vermont) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Beth Israel Deaconess Hospital - Milton | Milton, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
New England Family Foot Care Llc | 4385978253 | 2 |
News Archive
COSMIC-3D, the most comprehensive system for exploring cancer mutations in three dimensions, is launched today by COSMIC, based at the Wellcome Trust Sanger Institute, in collaboration with Astex Pharmaceuticals, Cambridge, UK.
Envoy Therapeutics, Inc., a newly formed drug discovery company, today announced that it has secured a loan from Takeda Research Investment (TRI) which Envoy may elect to convert to Envoy preferred stock should the company complete a second private equity financing. TRI will receive certain rights from Envoy related to a specific therapeutic field while scientists at the two companies craft a broad scientific research alliance.
How often are safety concerns raised about a drug after it's been approved by the FDA? Nicholas Downing, MD, of the Department of Medicine at Brigham and Women's Hospital, and colleagues have found that for drugs approved between 2001 and 2010, nearly 1 in 3 had a postmarket safety event.
A study carried out by the Primary Care Research Group at the Peninsula College of Medicine and Dentistry, supported by the National Institute for Health Research (NIHR) and NIHR PenCLAHRC, has analysed the results of an exercise programme to prevent falls in those with Parkinson's disease.
› Verified 1 days ago
Provider Name | New England Family Foot Care Llc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1598228124 PECOS PAC ID: 4385978253 Enrollment ID: O20190626001994 |
News Archive
COSMIC-3D, the most comprehensive system for exploring cancer mutations in three dimensions, is launched today by COSMIC, based at the Wellcome Trust Sanger Institute, in collaboration with Astex Pharmaceuticals, Cambridge, UK.
Envoy Therapeutics, Inc., a newly formed drug discovery company, today announced that it has secured a loan from Takeda Research Investment (TRI) which Envoy may elect to convert to Envoy preferred stock should the company complete a second private equity financing. TRI will receive certain rights from Envoy related to a specific therapeutic field while scientists at the two companies craft a broad scientific research alliance.
How often are safety concerns raised about a drug after it's been approved by the FDA? Nicholas Downing, MD, of the Department of Medicine at Brigham and Women's Hospital, and colleagues have found that for drugs approved between 2001 and 2010, nearly 1 in 3 had a postmarket safety event.
A study carried out by the Primary Care Research Group at the Peninsula College of Medicine and Dentistry, supported by the National Institute for Health Research (NIHR) and NIHR PenCLAHRC, has analysed the results of an exercise programme to prevent falls in those with Parkinson's disease.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Jeffrey Pantano, DPM 221 Depot St, Bennington, VT 05201-1815 Ph: () - | Dr Jeffrey Pantano, DPM 100 Hospital Dr, Bennington, VT 05201-5004 Ph: (802) 442-6361 |
News Archive
COSMIC-3D, the most comprehensive system for exploring cancer mutations in three dimensions, is launched today by COSMIC, based at the Wellcome Trust Sanger Institute, in collaboration with Astex Pharmaceuticals, Cambridge, UK.
Envoy Therapeutics, Inc., a newly formed drug discovery company, today announced that it has secured a loan from Takeda Research Investment (TRI) which Envoy may elect to convert to Envoy preferred stock should the company complete a second private equity financing. TRI will receive certain rights from Envoy related to a specific therapeutic field while scientists at the two companies craft a broad scientific research alliance.
How often are safety concerns raised about a drug after it's been approved by the FDA? Nicholas Downing, MD, of the Department of Medicine at Brigham and Women's Hospital, and colleagues have found that for drugs approved between 2001 and 2010, nearly 1 in 3 had a postmarket safety event.
A study carried out by the Primary Care Research Group at the Peninsula College of Medicine and Dentistry, supported by the National Institute for Health Research (NIHR) and NIHR PenCLAHRC, has analysed the results of an exercise programme to prevent falls in those with Parkinson's disease.
› Verified 1 days ago
Mccamie Dearmon Patterson, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 100 Hospital Dr, Bennington, VT 05201 Phone: 802-442-6361 | |
Krishna Gathani, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 100 Hospital Dr, Bennington, VT 05201 Phone: 802-442-6361 | |
William J Sarchino, Dpm Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 343 Dewey St, Bennington, VT 05201 Phone: 802-442-2034 | |
Richard S. Donela Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 213 School St, Bennington, VT 05201 Phone: 802-442-8448 | |
Daniel Hennessey, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 100 Hospital Dr, Bennington, VT 05201 Phone: 802-447-5010 | |
Dr. William J Sarchino, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 343 Dewey St, Bennington, VT 05201 Phone: 802-442-2034 Fax: 802-442-2748 |